BridgeBio Pharma
BBIO
Reported
Thursday, February 20
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.09 | -1.40 | -0.31 | -28.44% |
| Revenue | 4.04M | 5.88M | 1.84M | 45.59% |
WhatIF - Earnings
EPS Missed Expectations by -$0.31
BridgeBio Pharma (BBIO:NASDAQ) has never missed EPS by this much before
There’s a first time for everything